Catherine Bottomley, n/a

Director, Clinical Outcome Assessment
Clarivate
London, United Kingdom

Disclosure information not submitted.

Presentation(s):

• MON-728 - Patient-reported improvements in appetite control, quality of life, and work-related outcomes following tirzepatide treatment for obesity or overweight in the US: Results from 3-month PERCEPTIONS survey

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT